NCT04134923View on ClinicalTrials.gov

Imaging Biomarkers in Preclinical and Symptomatic AD

RecruitingOBSERVATIONAL
Enrollment

375

Participants

Timeline

Start Date

June 8, 2021

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2029

Conditions
Alzheimer Disease
Interventions
DRUG

[11C] Pittsburgh Compound-B (PIB)

Participants will receive a single intravenous bolus injection of 6.0 - 20.0 mCi (222-740 MBq) of the investigational radiotracer \[11C\] PIB. Participants will then undergo a \[11C\] PIB PET/CT scan conducted in the Center for Clinical Imaging Research (CCIR) facility.

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Tammie L. S. Benzinger, MD, PhD

OTHER